Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TDOC Teladoc Health Inc
- Stocks
- Healthcare
- NYSE: TDOC
Price (delayed)
$7.12
Market cap
$1.25B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.9
Enterprise value
$1.63B
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals
Highlights
TDOC's quick ratio has dropped by 55% year-on-year and by 7% since the previous quarter
Teladoc Health's equity has decreased by 38% YoY and by 4.3% QoQ
Key stats
What are the main financial stats of TDOC
Market
Valuations
Earnings
Shares outstanding
175.43M
Market cap
$1.25B
Enterprise value
$1.63B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.64
Revenue
$2.55B
Gross profit
$1.8B
Operating income
-$1.05B
Net income
-$1.01B
EBIT
-$1B
EBITDA
-$629.29M
Free cash flow
$180.55M
Per share
Balance sheet
Liquidity
EPS
-$5.9
EPS diluted
-$5.9
Free cash flow per share
$1.04
Book value per share
$8.22
Revenue per share
$14.66
TBVPS
$10.15
Total assets
$3.44B
Total liabilities
$2.02B
Debt
$1.58B
Equity
$1.43B
Working capital
$649.41M
Debt to equity
1.1
Current ratio
1.68
Quick ratio
1.5
Net debt/EBITDA
-0.61
Margins
Efficiency
Dividend
EBITDA margin
-24.7%
Gross margin
70.5%
Net margin
-39.7%
Operating margin
-41.3%
Return on assets
-28.9%
Return on equity
-68.3%
Return on invested capital
-85.9%
Return on capital employed
-40.2%
Return on sales
-39.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TDOC stock price
How has the Teladoc Health stock price performed over time
Intraday
0.85%
1 week
2.15%
1 month
0.85%
1 year
-34.5%
YTD
-21.67%
QTD
-10.55%
Financial performance
How have Teladoc Health's revenue and profit performed over time
Revenue
$2.55B
Gross profit
$1.8B
Operating income
-$1.05B
Net income
-$1.01B
Gross margin
70.5%
Net margin
-39.7%
The operating margin has contracted by 4% from the previous quarter
Teladoc Health's gross profit has decreased by 3% YoY
TDOC's operating income is down by 3.3% from the previous quarter
TDOC's revenue is down by 2.5% year-on-year
Price vs fundamentals
How does TDOC's price correlate with its fundamentals
Growth
What is Teladoc Health's growth rate over time
Valuation
What is Teladoc Health stock price valuation
P/E
N/A
P/B
0.87
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.64
The stock's price to book (P/B) is 59% less than its 5-year quarterly average of 2.1 and 13% less than its last 4 quarters average of 1.0
Teladoc Health's equity has decreased by 38% YoY and by 4.3% QoQ
The P/S is 93% below the 5-year quarterly average of 6.6 and 18% below the last 4 quarters average of 0.6
TDOC's revenue is down by 2.5% year-on-year
Efficiency
How efficient is Teladoc Health business performance
Teladoc Health's ROE has decreased by 16% from the previous quarter
Teladoc Health's return on invested capital has decreased by 15% QoQ
TDOC's return on assets is down by 7% since the previous quarter
The company's return on sales fell by 4% QoQ
Dividends
What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TDOC.
Financial health
How did Teladoc Health financials performed over time
Teladoc Health's total assets is 71% higher than its total liabilities
The current ratio has dropped by 56% year-on-year and by 5% since the previous quarter
TDOC's quick ratio has dropped by 55% year-on-year and by 7% since the previous quarter
TDOC's debt is 10% more than its equity
The debt to equity has soared by 59% YoY and by 3.8% from the previous quarter
Teladoc Health's equity has decreased by 38% YoY and by 4.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.